Ataídes celebrates the release of anti-obesity medications.
Senator Ataídes Oliveira, gubernatorial candidate for the "Reage Tocantins" coalition, celebrated the Senate's approval of the Legislative Decree revoking the Anvisa resolution and allowing the sale of appetite suppressant medications; "This restriction represented a setback for Brazil, as obesity is becoming an epidemic that must be controlled," said the senator; in 2011, Resolution No. 52 of the National Health Surveillance Agency (Anvisa) prohibited the use of the substances amfepramone, femproporex, sibutramine, and mazindol, as well as their salts and isomers.
Tocantins 247 - Legislative Decree Project No. 52 of 2014 (PDS 52), which deals with the release of appetite suppressant medications and proposes to suspend the Anvisa Resolution, was approved this Tuesday, the 02nd, in a symbolic vote in the Senate plenary. For the Senator from Tocantins, Ataídes Oliveira, "this restriction constituted a setback for Brazil, as obesity is becoming an epidemic that must be controlled."
In 2011, Resolution No. 52 of the National Health Surveillance Agency (Anvisa) prohibited the use of the substances amfepramone, femproporex, sibutramine, and mazindol, as well as their salts and isomers. "The medications in question can be useful for many patients who, despite several attempts and much effort, are unable to achieve changes in their lifestyle habits and lose weight," emphasizes Ataídes Oliveira.
The project was reported taking due precautions, with the doctor responsible for prescribing the medication and Anvisa (Brazilian Health Regulatory Agency) overseeing its use. "The responsibility lies with the medical profession; nobody is going to go around buying medication indiscriminately at pharmacies," emphasizes Ataídes.